Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
clinical trials
life sciences
national blog main
biotech
fda
national top stories
new york blog main
new york top stories
480 biomedical
abbvie
acorda therapeutics
aimmune therapeutics
allergy
ampyra
anaphylaxis
andrew oxtoby
apokyn
apomorphine
arsenal medical
bob langer
boston
boulder/denver blog main
boulder/denver top stories
chronic rhinosinusitis
covid-19
dalfampridine
daniel edelman
deals
detroit blog main
detroit top stories
drug delivery
duopa
eosinophilic esophagitis
food allergy
genzyme
george whitesides
immunotherapy
inbrija
What
late
3
×
approved
drug
fda
friday
new
therapeutics
treat
acorda
agency
aimmune
allergy
approval
awarded
biotech
company
cope
debut
developed
developing
disease
episodes
gets
help
immunotherapy
ipo
looms
lyra
markets
meant
medications
million
nod
nose
noses
oral
parkinson’s
patients
peanut
persistently
Language
unset
Current search:
late
×
" boston blog main "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms